The latest industry happenings from the past month, all in one place.
ClinOne has hired Cameron Snider as Vice President of Business Development.
Worldwide Clinical Trials announced the appointment of Steve Chriscoe as Executive Director for Oncology Project Management.
AiCure has appointed Rich Christie, MD, PhD, as Chief Medical Officer; Earnest Offley as Vice President of People Operations; and Brian O'Hara as Senior Director of Solution Consulting.
Calyx announced that global regulators have approved 500 medical treatments using their Interactive Response Technology solution.
The Illingworth Research Group was recognized with a 2021 Queen’s Award for Enterprise for International Trade.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.